Ref.: BL-RE-162033Manufacturer ref.: EHGPNMBX5 5 x 96 tests
€2,950.00 excl. VAT
Kit ELISA Osteoactivin sandwich (GPNMB) (human): quantitative determination of Hu GPNMB in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu GPNMB.
Accession number
Q14956
Dose range
49.15 pg/ml to 12.000 pg/ml
Sensitivity of the dosage
45 pg/ml
Calibration range
45 pg/ml to 12 000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA Osteoactivin sandwich (GPNMB) (human): quantitative determination of Hu GPNMB in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu GPNMB.
Kit ELISA Osteoactivin sandwich (GPNMB) (human): quantitative determination of Hu GPNMB in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu GPNMB.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
The protein encoded by this gene is a transmembrane glycoprotein type I that shows homology with the precursor of pMEL17, a melanocyte-specific protein. GPNMB is expressed in human xenografts and cell lines with weak metastases but is not expressed in highly metastatic cell lines. GPNMB may be involved in stunting and reduction of metastatic potential. Two variants of transcription coding different isoforms were found for this gene.
Sensitivity
Sensitivity of dosage: 45 pg/ml.
Measurement range
Dosing range: 49.15 pg/ml to 12.000 pg/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Specificity
This pair of antibodies used by ELISA detects human osteoactivin. It showed less than 20% cross-reactivity with recombinant mouse l-osteoactivin.